|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of goods sold | |||||
| Gross loss | |||||
| General and administrative | |||||
| Research and development | |||||
| Exploration | |||||
| Impairment of assets | |||||
| Impairment charge on held-for-sale assets | |||||
| Total operating expenses | |||||
| Net loss before other income (expense) | |||||
| Other income (expense) | |||||
| Interest income (expense) | |||||
| Amortization and accretion of financing costs | |||||
| Unrealized loss on investment | |||||
| Change in fair value of derivative liability | |||||
| Loss on debt extinguishment | |||||
| Loss on private placement | |||||
| Change in fair value of liability-classified financial instruments | |||||
| Credit loss on receivable pursuant to share purchase agreement (Tysadco) | |||||
| Other income | |||||
| Total other income (expense) | |||||
| Net loss attributable to common stockholders | |||||
| Net loss per share, basic | |||||
| Net loss per share, diluted | |||||
| Weighted average shares outstanding, basic | |||||
| Weighted average shares outstanding, diluted | |||||
Loading...